Eli Lilly is in advanced talks to buy Kelonia Therapeutics for more than $2 billion
businesssciencepharma 4 posts · 4 accounts
A transaction above $2 billion would put another multibillion-dollar cancer-biotech acquisition on the table for Eli Lilly.
From the sources (4 posts)
@wsjmarketsEli Lilly is in advanced talks to acquire Kelonia Therapeutics for more than $2 billion, according to people familiar with the matter
@firstsquawkELI LILLY IS IN ADVANCED NEGOTIATIONS TO ACQUIRE CANCER BIOTECH FIRM KELONIA THERAPEUTICS FOR OVER $2 BILLION. - WSJ
@exec_sumBREAKING: Eli Lilly is in advanced talks to acquire cancer biotech Kelonia Therapeutics for over $2B
@reuterslegalEli Lilly is in advanced talks to acquire Kelonia Therapeutics for more than $2 billion, the Wall Street Journal reported on Sunday.